Steffen Lang, President, Operations at Novartis, shares how the company is reimagining supply chains to bring life-changing medicines to patients worldwide

Steffen Lang, President, Operations at Novartis, shares how the company is reimagining supply chains to bring life-changing medicines to patients worldwide

For patients, even the most advanced medicine only matters if it arrives when and where it’ s needed. That’ s why innovative Swiss medicines company Novartis has built its operations network for speed, reliability and reach – making and delivering increasingly complex therapies for people around the world. Leading this effort is Steffen Lang, President, Operations, who has spent three decades helping shape how the company manufactures and supplies medicines globally. With roots stretching back more than 250 years, Novartis has a long track record of pioneering innovation. The company continues to transform breakthroughs into medicines that redefine what’ s possible for patients. At its core, this story explores how Novartis, guided by its mission to discover new ways to improve and extend people’ s lives, has had to rethink how it plans, produces and delivers treatments at a global scale. For the company, this has often included building reliable supply for therapies that are often complex, personalised and time-sensitive.